Background and aims: Obesity is associated with a blunted b-adrenoceptor-mediated lipolysis and fat oxidation. We investigated whether polymorphisms in codon 16, 27 and 164 of the b 2 -adrenoceptor gene (ADRB2) and exon 10 of the G protein b 3 -subunit gene (GNB3) are associated with alterations in in vivo lipolysis and fat oxidation. Design and methods: Sixty-five male and 43 female overweight and obese subjects (body mass index (BMI) range: 26.1-48.4 kg/m 2 ) were included. Energy expenditure (EE), respiratory quotient (RQ), circulating free fatty acid (FFA) and glycerol levels were determined after stepwise infusion of increasing doses of the non-selective b-agonist isoprenaline (ISO). Results: In women, the Arg16 allele of the ADRB2 gene was associated with a blunted increase in circulating FFA, glycerol and a decreased fat oxidation during ISO stimulation. In men, the Arg16 allele was significantly associated with a blunted increase in FFA but not in glycerol or fat oxidation. Conclusion: These results suggest that genetic variation in the ADRB2 gene is associated with disturbances in in vivo b-adrenoceptor-mediated lipolysis and fat oxidation during b-adrenergic stimulation in overweight and obese subjects; these effects are influenced by gene-gender interactions.
Introduction
Obesity is characterized by increased circulating free fatty acid (FFA) concentrations and increased triglyceride (TG) storage within adipose tissue. In vivo studies have shown that the development or maintenance of increased adipose tissue stores might be promoted by a blunted lipolytic response and fat oxidation after b-adrenergic stimulation or exercise in obese or obese type 2 diabetic subjects. [1] [2] [3] [4] This blunted b-adrenoceptor-mediated lipolysis and fat oxidation persisted after weight reduction, indicating that this disturbance may be an early, even primary factor, in the development or maintenance of increased adipose stores. 1 There are indications that the blunted b-adrenergically mediated lipolysis in obesity may be related to an impaired function or a reduced number of adipocyte beta-2 (b 2 ) adrenoceptors. 5, 6 b 2 -Adrenoceptors are stimulatory G-protein-coupled (G s ) receptors. The b 2 -adrenoceptor (ADRB2) gene is encoded by an intronless gene on chromosome 5q31-q32. 7, 8 Several polymorphisms of the human ADRB2 gene have been described. 9, 10 Among these, three common single-nucleotide polymorphisms (SNPs) result in the substitution of an amino acid. One is located at codon 16, substituting arginine for glycine (Arg16Gly). The other one is located at codon 27, substituting glutamic acid for glutamine (Gln27Glu). Both variants are located in the extracellular amino-terminal region of the receptor and alter cellular trafficking and desensitization of the receptor. 11 Previous studies have reported associations between codons 16 and 27 polymorphisms and obesity, insulin resistance and hypertension. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] Finally, the substitution of isoleucine for threonine at codon 164 (Thr164Ile), in the receptor transmembrane-spanning domains, alters agonist binding and decreases coupling of the G s protein to the receptor. 23, 24 There is evidence from in vitro studies that some of these receptor variants might be important for catecholamine-induced adipocyte lipolysis in humans. 16, 25 Furthermore, polymorphisms in G proteins involved in catecholamine signaling may alter corresponding receptor and hormone function. Recently, a common polymorphism substituting a cytosine for a thymine at position 825 (C825T) in exon 10 of the G-Protein b 3 -subunit (GNB3) gene (chromosome 12p13), coding an isoform of the G protein b subunit (Gb 3 ), has been identified. 26 G s deficiency is also observed in obesity and the C825T polymorphism is associated with obesity and hypertension in both white and non-white populations. [27] [28] [29] [30] [31] [32] [33] [34] In vitro studies indicated that the 825T variant of Gb 3 in its homozygous form was associated with a decreased amount of Gb 3 in fat cells, thereby inhibiting signaling through b 1 -, b 2 -and a 2 -adrenoceptors, resulting in decreased catecholamine action and blunted lipolysis in isolated subcutaneous adipocytes of male and female obese subjects. 35 Thus, there are indications that polymorphisms in the ADRB2 gene and the GNB3 gene may be related to an impaired in vitro lipolytic response. So far, however, few in vivo lipolysis studies on these polymorphisms have been performed. For this reason, the present study investigated the effect of genetic variation in the ADRB2 and the GNB3 gene on in vivo lipolysis and fat oxidation in overweight and obese subjects. . Exclusion criteria were weight change 43 kg within 3 months before the study started, drug-treated hypertension, diabetes or hyperlipidemia, thyroid disease, surgically treated obesity, pregnancy, alcohol or drug abuse and participation in other simultaneous ongoing trials. All subjects were recruited by means of an advertisement in a local newspaper. All subjects were in good health as assessed by medical history and physical examination and were not taking any medication. A normal resting electrocardiogram (ECG) and blood pressure were a prerequisite for participation. The study protocol was reviewed and approved by the Medical Ethical Review Committee of Maastricht University. The subjects were informed in detail about the investigation and their consent was obtained before participating in the study.
Methods

Subjects
Anthropometric measurements
Body weight was determined on an electronic scale, accurate to 0.1 kg. Waist and hip circumference measurements to the nearest 1 cm were made with the subjects standing upright. BMI was calculated as body weight in kilograms divided by squared height in meters. Body density was obtained by underwater weighing with residual pulmonary volume measurement by the helium dilution method (Volugraph 2000, Mijnhardt) and was converted to percent body fat using the equation of Siri. 36 Fat mass (FM) and fat-free mass (FFM) were calculated from the percent body fat and body weight.
Study design
The subjects arrived at the laboratory at 0800 after an overnight fast (of at least 12 h) by car or public transport. They were studied while resting supine on a comfortable bed in a room kept at 23-251C. At the beginning of the experiment, a catheter was inserted into a forearm vein for blood sampling. A second catheter was inserted into the contralateral arm for infusion of the non-selective b-agonist isoprenaline (ISO , each dose for 30 min. At the end of each infusion period, venous blood samples were taken, centrifuged and stored at À801C until further analysis. During ISO infusion, heart rate was kept under close observation by means of an ECG. When the heart rate increased by more than 30 beats/min above baseline or in case of an irregular heart rhythm, ISO infusion was stopped.
Genetic analysis
Genomic DNA was extracted from peripheral blood leukocytes by digestion with protein K followed by phenol/ chloroform extraction. Amplification of the relevant segments of the ADRB2 and GNB3 genes was performed by polymerase chain reaction (PCR) as previously described. 16, 35 PCR products were digested at 371C for 1 h using BsrDI, ItaI, MnlI or BseDI. The digested fragments were visualized using ethidium bromide staining and UV-transmitted light. Finally, we evaluated the accuracy of the restriction fragment length polymorphism (RFLP) method by direct sequencing of random samples and got 100% agreement. In addition, two persons independently evaluated samples and identical results were obtained.
Biochemical analysis
Whole blood was collected in tubes containing ethylene diamine tetraacetic acid (EDTA) and centrifuged for 10 min at 3000 rpm (41C) and the plasma removed for the enzymatic calorimetric quantitation of FFA (NEFA C kit, Wako, Neuss, Germany) and glycerol (Boehringer, Mannheim, Germany) on a COBAS FARA centrifugal spectrometer (Roche Diagnostica). Standard samples with known concentrations were included in each run for quality control. 
Statistical analysis
All statistical calculations were performed with SPSS for Macintosh (version 11.0; SPSS Inc., Chicago, IL, USA). The initial statistical analysis, performed for the whole group (n ¼ 108), indicated a significant gender effect for the Arg16 allele on lipolytic parameters (iAUC DFFA; P ¼ 0.01, allelgender interaction) and fat oxidation (iAUC DRQ; P ¼ 0.042). For this reason, the presented analysis is stratified by gender. The effect of genotypes on lipolytic responses and fat oxidation was investigated using analysis of variance (ANOVA) (adjusted for age and BMI). Post hoc testing was performed by Student's unpaired t-test with Bonferroni correction. Linkage disequilibrium was estimated according to Devlin et al. 37 Diplotype analysis were performed as described before. 38, 39 The goodness of fit between observed and expected genotype frequency (Hardy-Weinberg equilibrium, HWE) was statistically tested using the w 2 -test. 40 Allele and genotype frequency distributions for the whole group (n ¼ 108) are presented in Table 2 . Energy expenditure (EE) was adjusted for FFM by means of covariance analysis (ANCOVA). The ISO-induced effect on fat oxidation (RQ), thermogenesis (EE) and lipolysis (FFA, glycerol) were expressed as incremental area under the curve (iAUC) above baseline, calculated according to the trapezium rule. All data are represented as mean7standard error of the mean (s.e.m.). Po0.05 was considered as statistically significant.
Power calculation
A power analysis was performed to estimate the sample size required enabling the accurate and reliable statistical judgments for the two-way parametric statistics. There are little or no published studies regarding the effect of ADRB2 and GNB3 gene variants and whole body lipolysis and fat oxidation, although the results of in vitro studies in human adipocytes support a major effect. We therefore estimated our sample size using published data of the effect of badrenergic stimulation on whole body lipolysis and fat oxidation. 
Results
As mentioned under statistical methods, initial analysis performed for the whole group (n ¼ 108) indicated a significant gender effect for the Arg16 allele. For this reason, the presented analysis is stratified by gender.
Subjects
Anthropometric and metabolic characteristics of the study subjects are shown in Table 1 . Women had significantly higher percentage body fat, a lower waist-hip ratio and were significantly younger compared with male participants. Additionally, women had a significantly higher fasting FFA level. No significant differences were observed for BMI, resting EE (adjusted for FFM) and fasting glycerol levels between genders.
Effect of codon 16 and 27 of the b 2 -adrenoceptor gene (ADRB2) on fat oxidation and lipolysis after b-adrenergic stimulation Allele and genotype frequency distributions for the ADRB2 gene are shown in Table 2 . For women, ANOVA analysis Figure 1 ), glycerol (P ¼ 0.037, see Figure 1 ) and fat oxidation (P ¼ 0.042, see Figure 2 ), even after correction for age and BMI. Post hoc analysis indicated that in women the Arg16Gly genotype was significantly associated with a blunted increase in circulating FFA (iAUC DFFA after ISO: 379735 vs 493740 mmol/l, P ¼ 0.041, see Figure 1 ) and glycerol (iAUC DGlycerol after ISO: 86711 vs 128714 mmol/l, P ¼ 0.026, see Figure 1 ) during stimulation compared with female Gly16 homozygotes. In addition to a blunted lipolytic response, female Arg16Gly heterozygotes showed a blunted increase in fat oxidation compared with Gly16 homozygotes (iAUC DRQ after ISO: 0.00470.007 vs -0.01770.008, P ¼ 0.043, see Figure 2 ) and a comparable thermogenic response (iAUC DEE after ISO: 0.5170.07 vs 0.7070.09 kJ/min, NS). Because lipolytic response and fat oxidation appeared to be reduced in both Arg16Gly and Arg16Arg carriers, Arg16 heterozygotes and homozygotes were combined into one group (Arg16Gly þ Arg16Arg). Female Arg carriers (Arg16-Gly þ Arg16Arg) appeared to have a blunted increase in circulating FFA (382731 vs 493743 mmol/l, P ¼ 0.042) and glycerol (89710 vs 129718 mmol/l, P ¼ 0.038) after b-adrenergic stimulation compared with Gly16Gly homozygotes. This altered lipolytic response in female Arg carriers (Arg16Gly þ Arg16Arg) was accompanied by a decreased fat oxidation after stimulation (iAUC DRQ after ISO 0.00370.007 vs À0.01670.005, P ¼ 0.024). No differences were found in ISO-induced thermogenesis (iAUC DEE after ISO: 0.5770.07 vs 0.7070.09 kJ/min, NS), body weight, BMI and other anthropometric variables.
Data in male overweight subjects were less consistent: ANOVA analysis (adjusted for age and BMI) indicated only a significant genotype effect of codon 16 and a blunted increase in FFA (P ¼ 0.022, see Figure 1 ). Post hoc analysis revealed that male carriers of the Arg16Gly genotype had a significantly blunted increase in circulating FFA during badrenergic stimulation compared with male Gly16 homozygotes, (266730 vs 401734 mmol/l, P ¼ 0.005; see Figure 1 ). However, this blunted FFA response was not accompanied by a blunted increase in circulating glycerol (see Figure 1 ) nor a decreased fat oxidation (iAUC DRQ, see Figure 2 ). Furthermore, taking Arg16 heterozygotes and homozygotes together into one group, (Arg16Gly þ Arg16Arg) carriers showed a blunted increase in circulating FFA (281721 vs 406741 mmol/l, P ¼ 0.004) compared with Gly16Gly carriers, whereas ISO-induced changes in glycerol, thermogenesis and RQ were comparable between groups. Again, no differences were found in body weight, BMI and other anthropometric variables.
For neither female nor male subjects associations were found between genetic variation in codon 27 and 164 of the b 2 -adrenoceptor gene (ADRB2) and alterations in fat oxidation or lipolytic response during b-adrenergic stimulation.
Diplotype analysis
Three homozygous and functional diplotypes were investigated in both male and female subjects: Gly16Gly/Glu27Glu, Arg16Arg/Gln27Gln and Gly16Gly/Gln27Gln. The diplotype frequency distribution is depicted in Table 2 . From the 55 men carrying the Gly16 allele, 47 also carried the Glu27 allele (w 2 ¼ 32.653, Po0.0001), indicating linkage disequilibrium (|D 0 '| ¼ 0.854, r 2 ¼ 0.494). 37 In 21.5% (n ¼ 14) of the men and 14% (n ¼ 6) of the women, the Gly16Gly/Glu27Glu diplotype was apparent. This diplotype was not associated with a decreased lipolytic response (iAUC DFFA and iAUC Dglycerol) or fat oxidation (iAUC DRQ) in male or female ADRB2 gene in obesity JWE Jocken et al subjects. Nevertheless, female carriers (n ¼ 6) of the Gly16Gly/Glu27Glu diplotype had lower fasting FFA levels (431749 vs 636732 mmol/l, Po0.05) compared with female non-carriers (n ¼ 37). No differences were found in body weight, BMI and other anthropometric variables. The other two diplotypes (Arg16Arg/Gln27Gln and Gly16Gly/ Gln27Gln) were also not associated with an altered fat oxidation, thermogenic or lipolytic response in this population. Owing to the relatively low sample size, we were not able to identify b 2 -adrenoceptor haplotypes for codons 16, 27 and 164 with a frequency 45%.
Effect of the C825T polymorphism in exon 10 of the G protein beta-3 subunit (GNB3) gene on fat oxidation and lipolysis Allele and genotype frequency distributions for the GNB3 gene are shown in Table 2 . Male TT carriers (n ¼ 4) showed a tendency toward a blunted increase in circulating FFA (iAUC DFFA after ISO: 173746 vs 435732 mmol/l) and glycerol (iAUC DGlycerol after ISO: 47714 vs 10778 mmol/l) after b-adrenergic stimulation compared with CT carriers (n ¼ 29). Similar results were obtained for male CC carriers (n ¼ 32). Unfortunately, the number of subjects in the TT group (n ¼ 4) were too small to perform statistical analysis. In female overweight subjects, no associations were found for the C825T polymorphism and an altered lipolytic response, thermogenesis or fat oxidation.
Discussion
To the best of our knowledge, this is the first study to investigate the association between genetic variability in the ADRB2 gene and GNB3 gene and in vivo lipolysis and fat oxidation in overweight and obese men and women. The major findings of our study are as follows: firstly, genetic variability in codon 16 of the ADRB2 gene was associated with a blunted increase in circulating FFA and glycerol during b-adrenergic stimulation with the nonselective ISO in female subjects. In male subjects, codon 16 was associated with a blunted ISO-induced increase in FFA, whereas no difference in glycerol was apparent. In female subjects, this blunted lipolytic response was also accompanied with a reduced fat oxidation. Finally, the TT genotype of the GNB3 gene was associated with a blunted increase in FFA and glycerol in male subjects. This blunted lipolytic response was not accompanied by a reduced fat oxidation.
Large et al. 16 showed that the Arg16Gly genotype was associated with an in vitro fivefold increase in agonist sensitivity of the b 2 -adrenoceptor in abdominal subcutaneous adipocytes of overweight female subjects, without any significant effect on glycerol release. In our study, the Arg16 allele was associated with blunted ISO-induced responses in FFA, glycerol and fat oxidation (iAUC DRQ) in women and a blunted increase in FFA in men. The reason for this apparent discrepancy with our findings may be related to the differences in our in vivo vs the in vitro approach to study lipolysis. In the in vitro situation, in vivo factors like the neuroendocrine environment and local adipocyte blood flow are not taken into account. In addition, the majority of in vitro studies are performed on adipocytes derived from the subcutaneous region in both genders. It should be mentioned that there are major differences in catecholamine-induced lipolysis between depots (subcutaneous vs visceral and gluteofemoral) and also gender differences in body fat distribution. [43] [44] [45] Our data indicate that variability in codon 16 of the ADRB2 gene may contribute to a reduced in vivo b-adrenoceptor-mediated lipolysis and fat oxidation, [1] [2] [3] [4] indicating that these blunted responses may be important primary factors in obesity. Besides looking at individual codons, we also studied the effect of diplotypes. We chose to study two common (410% in the population) and one less common (o5%) homozygous combination (Gly16Gly/Glu27Glu, Arg16Arg/ Gln27Gln and Gly16Gly/Gln27Gln), as they have been reported to have a significant effect on lipolysis. 38 In addition, these SNPs belong to the same pathway and transfection experiments showed that they are functional. 39 Finally, in our population, as has been reported before, there is strong linkage disequilibrium between codons 16 and 27. 46 Nevertheless, no effect of diplotypes on lipolytic, thermogenic response or fat oxidation was found in our study.
Only the Gly16Gly/Glu27Glu diplotype was associated with a lower fasting FFA concentration in female overweight subjects, which may possibly reflect a reduced rate of lipolysis in subcutaneous adipose tissue. 47 Finally, literature suggests that the Thr164Ile b 2 -adrenoceptor polymorphism is closely associated with Gly at position 16 and Gln at position 27. 39, 48 Nevertheless, due to the relatively low sample size, we were not able to identify b 2 -adrenoceptor haplotypes for codons 16, 27 and 164 with a frequency 45%.
38
The observed genotype frequency for the polymorphism in the GNB3 gene was similar to that previously reported in other Caucasian populations. 26, 31 Rydén et al. 35 showed that the T variant of this polymorphism was associated with a blunted in vitro responsiveness for the non-selective ISO in abdominal subcutaneous adipocytes of male and female overweight subjects. In contrast with Ryden et al. 35 we found a tendency toward a reduced lipolysis aney in male overweight subjects. It should be mentioned that our sample has no adequate power to provide a conclusive result about a genotype effect for the C825T polymorphism in the GNB3 gene. Thus, further studies are necessary to confirm our in vivo findings in a larger population. In summary, variation in codon 16 of the ADRB2 gene is associated with an impaired lipolytic response in male and female overweight and obese subjects and by a blunted fat oxidation in overweight and obese women. In conclusion, the present results suggest that genetic variability in the ADRB2 gene influences lipolysis regulation in vivo in overweight and obese subjects and that this is subject to gene-ADRB2 gene in obesity JWE Jocken et al gender interactions. This indicates that genetic variability in the ADRB2 gene may be an important factor in the development or progression of obesity and obesity-related disorders.
